Please assess the completion status of the following clinical trial:

Trial Title: Safer Conception Intervention for HIV-1 Serodiscordant Couples

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Couples~  * Immediate fertility intention~ * Sexually active (defined as having had vaginal intercourse at least 6 times in the previous three months)~ * Willing to enter the study as a couple and intending to remain as a couple for the next 12 months~For HIV-1 infected members of the couple (index participants)~* Able and willing to provide written informed consent~* HIV-1 infected based on positive rapid HIV-1 tests, according to national algorithm~* Not currently pregnant or breastfeeding~* No use of injectable contraception for the past 3 months~* Not currently enrolled in an HIV-1 treatment study~* No clear indication of infertility or subfertility, as determined by medical history~* Own a mobile phone for personal use, which operates on a telecom provider supported by the study SMS platform and is distinct from the mobile phone owned by the HIV-1 uninfected partner~* Know how to send and receive SMS~* Have regular access to electricity or an alternative means for charging a cell phone Literate in English, Kiswahili or Kikuyu~For HIV-1 uninfected members of the couple (partner participants)~* Able and willing to provide written informed consent~* HIV-1 uninfected based on negative HIV-1 rapid tests, both at study screening and at the enrollment visit~* Adequate renal function, defined by normal creatinine levels and estimated creatinine clearance ≥60 mL/min~* Not infected with hepatitis B virus, as determined by a negative hepatitis B surface antigen test~* Not currently pregnant or breastfeeding~* No use of injectable contraception for the past 3 months~* Not currently enrolled in an HIV-1 prevention clinical trial~* Enrollment of individuals with active and serious infections or active clinically significant medical problems will be at the discretion of the site investigator~* No clear indication of infertility or subfertility, as determined by medical history~* Own a mobile phone for personal use, which operates on a telecom provider supported by the study SMS platform and is distinct from the mobile phone owned by the HIV-1 infected partner~* Know how to send and receive SMS~* Have regular access to electricity or an alternative means for charging a cell phone~* Literate in English, Kiswahili or Kikuyu~For study clinicians and counselors~• Active involvement in safer conception counseling for couples and use of the tablet application during counseling sessions~Exclusion Criteria:~* For couples~  * Participated in the Partners PrEP Study or the Partners Demonstration Project For HIV-1 infected members of the couple (index participants)~ * Currently pregnant or breastfeeding~ * Used an injectable contraception in the past 3 months~ * Currently enrolled in an HIV-1 treatment study~ * Has a clear indication of infertility or sub-fertility, as determined by medical history~For HIV-1 uninfected members of the couple (partner participants):~* Infected with hepatitis B virus, as determined by a positive hepatitis B surface antigen test~* Currently pregnant or breastfeeding~* Used an injectable contraception in the past 3 months~* Currently enrolled in an HIV-1 prevention clinical trial~* Has a clear indication of infertility or subfertility, as determined by medical history~* Enrollment of individuals with active and serious infections or active clinically significant medical problems will be at the discretion of the site investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- HIV-1 serodiscordant couples (Type: None): Couples where one partner is HIV-1 infected and the other is uninfected, who will receive counseling on timed condomless sex, ART and PrEP adherence. The study intervention focuses on ART use by the HIV-1 infected partner, PrEP (Truvada) use by the HIV-1 uninfected partner, and timed condomless sex during the peri-conception period.

Based on this trial design, predict the completion outcome and termination type (if applicable).